FdaApplication
BLA 125509
Identifiers
- fda_app_no: BLA125509
Properties
| Property | Value |
|---|---|
| applicant_name | Elusys Therapeutics, Inc. |
| application_type | BLA |
| approval_date | 2016-03-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ANTHIM | OBILTOXAXIMAB | 600MG/6ML (100MG/ML) | Injection |
1 product